- Home
- AXSM vs IOVA Comparison
AXSM vs IOVA Comparison
Compare AXSM & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- IOVA
- Stock Information
- Founded
- AXSM 2012
- IOVA 2007
- Country
- AXSM United States
- IOVA United States
- Employees
- AXSM N/A
- IOVA N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AXSM Health Care
- IOVA Health Care
- Exchange
- AXSM Nasdaq
- IOVA Nasdaq
- Market Cap
- AXSM 4.4B
- IOVA 3.6B
- IPO Year
- AXSM 2015
- IOVA N/A
- Fundamental
- Price
- AXSM $95.84
- IOVA $10.15
- Analyst Decision
- AXSM Strong Buy
- IOVA Strong Buy
- Analyst Count
- AXSM 14
- IOVA 10
- Target Price
- AXSM $124.57
- IOVA $24.80
- AVG Volume (30 Days)
- AXSM 405.5K
- IOVA 5.8M
- Earning Date
- AXSM 11-04-2024
- IOVA 11-05-2024
- Dividend Yield
- AXSM N/A
- IOVA N/A
- EPS Growth
- AXSM N/A
- IOVA N/A
- EPS
- AXSM N/A
- IOVA N/A
- Revenue
- AXSM $291,489,000.00
- IOVA $32,772,000.00
- Revenue This Year
- AXSM $42.50
- IOVA $13,836.92
- Revenue Next Year
- AXSM $69.28
- IOVA $183.20
- P/E Ratio
- AXSM N/A
- IOVA N/A
- Revenue Growth
- AXSM 59.73
- IOVA 13669.75
- 52 Week Low
- AXSM $55.02
- IOVA $3.21
- 52 Week High
- AXSM $98.40
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- AXSM 64.19
- IOVA 49.83
- Support Level
- AXSM $89.24
- IOVA $8.80
- Resistance Level
- AXSM $96.71
- IOVA $10.93
- Average True Range (ATR)
- AXSM 3.66
- IOVA 0.68
- MACD
- AXSM 0.02
- IOVA -0.07
- Stochastic Oscillator
- AXSM 87.05
- IOVA 45.00
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.